- 询价
- eENZYME
- IA-H1-CA3-100ug
- 2026年02月19日
企业认证
相关产品推荐更多 >
AffinityImmunoRat monoclonal antibody to Mouse IL-10 (Clone JES5-2A5)ab-131-148
询价DB BiotechDB Antigen retrieval solution, pH9, 10xconcentratedDB Retris - 500
询价
TAMRA Synthesis Column (5'-DMT-mdC(TEG-TAMRA)-Phos-CPG); 1000 Å, 50 nmol
询价Polycaprolactone-Poly(ethylene glycol)-b-Maleimide
询价
Neoprene Stopper, 1 pack
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
10
- 供应商：
北京柏瑞图科技有限公司
- 规格：
100ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PCR for the Detection of Influenza Viruses in Clinical Material
). Influenza A viruses are further divided into subtypes H1N1, H2N2 and H3N2, based on differences in the hemagglutinin (HA) and neuraminidase (NA) genes. The ability of influenza viruses to undergo antigenic change in HA and NA enables the virus to evade
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
A(H3N2) and A(H1N1) viruses, including the 2009 pandemic H1N1 strain. The limited pharmaceutical options currently available for control of influenza infections underscore the critical need for surveillance on NAI susceptibility of influenza viruses
技术资料暂无技术资料 索取技术资料
